|
US4069819A
(en)
|
1973-04-13 |
1978-01-24 |
Societa Farmaceutici S.P.A. |
Inhalation device
|
|
JPS61140520A
(ja)
|
1984-12-12 |
1986-06-27 |
Lion Corp |
アセチルサリチル酸製剤
|
|
FR2580634B1
(fr)
|
1985-04-19 |
1988-08-05 |
Rhone Poulenc Sante |
Nouveau derive de l'acide acetylsalicylique, sa preparation et les compositions pharmaceutiques qui le contiennent
|
|
DE3814856A1
(de)
|
1988-05-02 |
1989-11-16 |
Verla Pharm |
Mittel zur prophylaxe des herzinfarkts und zur verhuetung des reinfarkts
|
|
IT1228459B
(it)
|
1989-02-23 |
1991-06-19 |
Phidea S R L |
Inalatore con svuotamento regolare e completo della capsula.
|
|
US5327883A
(en)
|
1991-05-20 |
1994-07-12 |
Dura Pharmaceuticals, Inc. |
Apparatus for aerosolizing powdered medicine and process and using
|
|
US20070116761A1
(en)
|
1993-02-22 |
2007-05-24 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US5533502A
(en)
|
1993-05-28 |
1996-07-09 |
Vortran Medical Technology, Inc. |
Powder inhaler with aerosolization occurring within each individual powder receptacle
|
|
US5875776A
(en)
|
1996-04-09 |
1999-03-02 |
Vivorx Pharmaceuticals, Inc. |
Dry powder inhaler
|
|
KR20010111564A
(ko)
|
1998-11-12 |
2001-12-19 |
프랭크 쥐. 필키윅즈 |
흡입 시스템
|
|
CN1150895C
(zh)
|
1998-11-13 |
2004-05-26 |
杰格研究股份公司 |
用于吸入给药的干粉
|
|
US20030176421A1
(en)
|
1999-12-30 |
2003-09-18 |
Watson John W. |
Prokinetic agents for treating gastric hypomotility and related disorders
|
|
PL204106B1
(pl)
|
2000-02-28 |
2009-12-31 |
Pharmakodex Ltd |
Zestaw do dostarczania środka terapeutycznego
|
|
PE20011227A1
(es)
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
|
GB0010709D0
(en)
|
2000-05-03 |
2000-06-28 |
Vectura Ltd |
Powders for use a in dry powder inhaler
|
|
EP1177805A1
(en)
|
2000-07-31 |
2002-02-06 |
Maryland Financial Inc. |
Powder inhaler
|
|
US6613308B2
(en)
|
2000-09-19 |
2003-09-02 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
|
NZ526059A
(en)
|
2000-11-30 |
2005-05-27 |
Vectura Ltd |
Method of making composite active particles in the presence of an additive material for use in a pharmaceutical composition
|
|
WO2002051389A2
(en)
|
2000-12-22 |
2002-07-04 |
Aspen Aerogels, Inc. |
Aerogel powder comprising therapeutic agents
|
|
EP1238680B1
(en)
|
2001-03-05 |
2003-12-10 |
Ivo Pera |
Inhaling device for dispersing powdered medicaments contained in a capsule through the respiratory tract
|
|
US20060293217A1
(en)
|
2001-03-19 |
2006-12-28 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained release
|
|
US20040049022A1
(en)
|
2001-04-24 |
2004-03-11 |
Nyce Jonathan W. |
Composition & methods for treatment and screening
|
|
GB0129270D0
(en)
|
2001-12-06 |
2002-01-23 |
Pfizer Ltd |
Pharmaceutical combination
|
|
GB0129397D0
(en)
|
2001-12-07 |
2002-01-30 |
Pfizer Ltd |
Pharmaceutical combination
|
|
WO2003072080A1
(en)
|
2002-02-22 |
2003-09-04 |
Advanced Inhalation Research, Inc. |
Inhalable formulations for sustained release
|
|
US7405207B2
(en)
|
2002-06-17 |
2008-07-29 |
Epigenesis Pharmaceuticals, Inc. |
Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
|
|
AU2003276131A1
(en)
|
2002-06-18 |
2003-12-31 |
Epigenesis Pharmaceuticals, Inc. |
A dry powder oligonucleotide formulation, preparation and its uses
|
|
CN1694689A
(zh)
|
2002-09-30 |
2005-11-09 |
阿库斯菲尔公司 |
供吸入的缓释多孔微粒
|
|
GB0226105D0
(en)
|
2002-11-08 |
2002-12-18 |
St Georges S Entpr Ltd |
Pain relief agents
|
|
US7516741B2
(en)
|
2002-12-06 |
2009-04-14 |
Novartis Ag |
Aerosolization apparatus with feedback mechanism
|
|
SE0203687D0
(sv)
|
2002-12-13 |
2002-12-13 |
Ian Harwigsson Med Adagit Fa |
Pharmaceutical Porous Particles
|
|
AU2004229567A1
(en)
|
2003-04-09 |
2004-10-28 |
Wyeth |
Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1 (7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof
|
|
AU2004229446B2
(en)
|
2003-04-09 |
2010-02-25 |
Bgp Products Operations Gmbh |
Aerosolization apparatus with air inlet shield
|
|
GB0312419D0
(en)
|
2003-05-30 |
2003-07-02 |
Boots Healthcare Int Ltd |
Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess
|
|
SE527069C2
(sv)
|
2003-06-19 |
2005-12-13 |
Mederio Ag |
Förfarande och anordning för administrering av läkemedelspulver
|
|
US7041286B2
(en)
|
2003-07-23 |
2006-05-09 |
Nerenberg Arnold P |
Composition for mitigating a pernicious thrombotic event
|
|
JP2007502815A
(ja)
|
2003-08-20 |
2007-02-15 |
イーライ リリー アンド カンパニー |
Ppar調節因子
|
|
CN1838958A
(zh)
|
2003-08-22 |
2006-09-27 |
贝林格尔·英格海姆药物公司 |
治疗慢性阻塞性肺病和肺动脉高血压的方法
|
|
US20050249697A1
(en)
|
2003-09-24 |
2005-11-10 |
Uhrich Kathryn E |
Compositions and methods for the inhibition of bone growth and resorption
|
|
JP5303605B2
(ja)
*
|
2003-10-16 |
2013-10-02 |
第一三共ヘルスケア株式会社 |
サリチル酸類含有経口組成物
|
|
WO2005040163A1
(en)
|
2003-10-28 |
2005-05-06 |
Dr. Reddy's Laboratories Ltd |
Heterocyclic compounds that block the effects of advanced glycation end products (age)
|
|
WO2005041886A2
(en)
|
2003-10-31 |
2005-05-12 |
Metaphore Pharmaceuticals, Inc. |
Methods for generating or increasing revenues related to pain inhibitor commerce
|
|
US20070232575A1
(en)
|
2004-02-05 |
2007-10-04 |
Baulieu Etienne E |
Treatment of Pulmonary Artery Hypertension with Dhea, Dheas, Dhea Analogs, or Dhea Derivatives
|
|
AU2005216969A1
(en)
|
2004-02-23 |
2005-09-09 |
Prolexys Pharmaceuticals Inc. |
Non-peptidyl agents with pHSP20-like activity, and uses thereof
|
|
AU2005238291A1
(en)
|
2004-05-04 |
2005-11-10 |
Pfizer Inc. |
Substituted methyl aryl or heteroaryl amide compounds
|
|
US7189750B2
(en)
|
2004-05-05 |
2007-03-13 |
Renopharm Ltd. |
Thiazole-based nitric oxide donors having at least two thiazole moieties and uses thereof
|
|
US7244709B2
(en)
|
2004-05-10 |
2007-07-17 |
Nastech Pharamecutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of parathyroid hormone
|
|
WO2006017354A1
(en)
|
2004-07-13 |
2006-02-16 |
Pharmacofore, Inc. |
Compositions of nicotinic agonists and therapeutic agents and methods for treating or preventing disease or pain
|
|
WO2006017505A2
(en)
|
2004-08-04 |
2006-02-16 |
Schering Corporation |
Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
|
|
ATE539757T1
(de)
|
2004-11-02 |
2012-01-15 |
Univ Leland Stanford Junior |
Verfahren zur hemmung von nkt-zellen
|
|
GB0425758D0
(en)
|
2004-11-23 |
2004-12-22 |
Vectura Ltd |
Preparation of pharmaceutical compositions
|
|
GB0426301D0
(en)
*
|
2004-11-30 |
2004-12-29 |
Vectura Ltd |
Pharmaceutical formulations
|
|
EP1898911A1
(en)
*
|
2005-06-13 |
2008-03-19 |
Elan Pharma International Limited |
Nanoparticulate clopidogrel and aspirin combination formulations
|
|
TWI366460B
(en)
|
2005-06-16 |
2012-06-21 |
Euro Celtique Sa |
Cannabinoid active pharmaceutical ingredient for improved dosage forms
|
|
US20090220435A1
(en)
|
2005-07-27 |
2009-09-03 |
Nastech Pharmaceutical Company Inc. |
Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agents
|
|
JP2009504805A
(ja)
|
2005-08-09 |
2009-02-05 |
ナノバイオ コーポレーション |
抗炎症活性を有するナノエマルジョン組成物
|
|
ITMI20051999A1
(it)
|
2005-10-21 |
2007-04-22 |
Eratech S R L |
Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
|
|
US20070178166A1
(en)
|
2005-12-15 |
2007-08-02 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
MX2008007697A
(es)
|
2005-12-16 |
2008-09-26 |
Univ Kansas |
Nanocumulos para la distribucion de farmacos.
|
|
WO2007072503A2
(en)
|
2005-12-21 |
2007-06-28 |
Panacea Biotec Ltd. |
Combinations for managing inflammation and associated disorders
|
|
WO2007114881A1
(en)
|
2006-01-24 |
2007-10-11 |
Nexbio, Inc. |
Technology for preparation of macromolecular microspheres
|
|
GB0605723D0
(en)
|
2006-03-23 |
2006-05-03 |
3M Innovative Properties Co |
Powder filling processes
|
|
PT2068889T
(pt)
|
2006-08-10 |
2020-01-30 |
Roy C Levitt |
Anakinra para uso no tratamento da síndrome da bronquiolite obliterante
|
|
GB0617171D0
(en)
|
2006-08-31 |
2006-10-11 |
Generics Uk Ltd |
Novel compositions and methods
|
|
US20080066739A1
(en)
|
2006-09-20 |
2008-03-20 |
Lemahieu Edward |
Methods and systems of delivering medication via inhalation
|
|
US7767206B2
(en)
|
2006-10-02 |
2010-08-03 |
Amgen Inc. |
Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
|
|
GB0621957D0
(en)
|
2006-11-03 |
2006-12-13 |
Vectura Group Plc |
Inhaler devices and bespoke pharmaceutical compositions
|
|
GB0700839D0
(en)
|
2007-01-17 |
2007-02-21 |
Braithwaite Philip |
Device
|
|
EP1964564A1
(en)
|
2007-04-19 |
2008-09-03 |
LAB International SRL |
Breakthrough Pain Management
|
|
US8530463B2
(en)
|
2007-05-07 |
2013-09-10 |
Hale Biopharma Ventures Llc |
Multimodal particulate formulations
|
|
EP2170958A1
(en)
|
2007-06-13 |
2010-04-07 |
Amgen Inc. |
Il-17 heteromeric receptor complex
|
|
CA2693771A1
(en)
|
2007-07-13 |
2009-01-22 |
Abbott Biotechnology Ltd. |
Methods and compositions for pulmonary administration of a tnf.alpha. inhibitor
|
|
RU2010102865A
(ru)
|
2007-07-24 |
2011-08-27 |
НексБио, Инк. (US) |
Технология изготовления микрочастиц
|
|
WO2009019598A2
(en)
*
|
2007-08-03 |
2009-02-12 |
Dr. Reddy's Laboratories Ltd. |
Inhalation therapy for respiratory disorders
|
|
WO2009026434A1
(en)
|
2007-08-21 |
2009-02-26 |
Alkermes, Inc. |
Pulmonary pharmaceutical formulations
|
|
US9358242B2
(en)
|
2007-08-30 |
2016-06-07 |
Prelief Inc. |
Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
|
|
EP2227085A4
(en)
|
2007-12-06 |
2013-10-09 |
Berg Pharma Llc |
INGREDIBLE COMPOSITIONS WITH INCREASED BIOLOGICAL AVAILABILITY
|
|
US20090196930A1
(en)
|
2007-12-27 |
2009-08-06 |
Aires Pharmaceuticals, Inc. |
Aerosolized nitrite and nitric oxide -donating compounds and uses thereof
|
|
DE102008004386A1
(de)
|
2008-01-14 |
2009-07-23 |
Activaero Gmbh |
Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen
|
|
JP2011510017A
(ja)
|
2008-01-15 |
2011-03-31 |
ユニベルシテ・ドウ・ストラスブール |
治療薬として有用なレゾルシン酸ラクトンの合成
|
|
JP2011514335A
(ja)
|
2008-02-21 |
2011-05-06 |
アムジェン インコーポレイテッド |
Il−17ra−il−17rbアンタゴニストおよび該アンタゴニストの使用
|
|
EP2255797A4
(en)
|
2008-02-22 |
2011-09-07 |
Hanall Biopharma Co Ltd |
COMPOSITE PREPARATION
|
|
GB0803369D0
(en)
|
2008-02-25 |
2008-04-02 |
Helperby Therapeutics Ltd |
Biological materials and uses thereof
|
|
MX2010010877A
(es)
|
2008-04-04 |
2010-10-26 |
Irm Llc |
Compuestos y composiciones como inhibidores de itpkb.
|
|
CN102065694A
(zh)
|
2008-04-15 |
2011-05-18 |
萨可德公司 |
用于局部治疗免疫相关疾病的雾化的lfa-1拮抗剂
|
|
CA2722418C
(en)
|
2008-05-13 |
2013-09-17 |
Irm Llc |
Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors
|
|
US20110112134A1
(en)
|
2008-05-16 |
2011-05-12 |
Amira Pharmaceuticals, Inc. |
Tricyclic Antagonists of Prostaglandin D2 Receptors
|
|
EP2318049A1
(en)
|
2008-07-15 |
2011-05-11 |
Schering Corporation |
Intranasal compositions comprising a decongestant and a corticosteroid
|
|
WO2010007447A1
(en)
|
2008-07-18 |
2010-01-21 |
Prosonix Limited |
Process for improving crystallinity
|
|
WO2010011329A2
(en)
|
2008-07-23 |
2010-01-28 |
Map Pharmaceuticals, Inc. |
The delivery of powdered drug via inhalation
|
|
US8236786B2
(en)
|
2008-08-07 |
2012-08-07 |
Pulmagen Therapeutics (Inflammation) Limited |
Respiratory disease treatment
|
|
MX2011002688A
(es)
|
2008-09-12 |
2011-04-12 |
Critical Pharmaceuticals Ltd |
Mejoramientos en la absorcion de agentes terapeuticos a traves de las membranas mucosas o la piel.
|
|
PE20120647A1
(es)
|
2009-03-13 |
2012-05-31 |
Nucitec Sa De Cv |
Composiciones y metodos para el tratamiento y prevencion de la enfermedad cardiovascular
|
|
US20120046251A1
(en)
|
2009-04-06 |
2012-02-23 |
The Regents Of The University Of California |
Inhibitors of soluble epoxide hydrolase to inhibit or prevent niacin-induced flushing
|
|
CA2759026C
(en)
|
2009-04-20 |
2019-01-15 |
Auspex Pharmaceuticals, Inc. |
Piperidine inhibitors of janus kinase 3
|
|
US9101539B2
(en)
|
2009-05-15 |
2015-08-11 |
Shin Nippon Biomedical Laboratories, Ltd. |
Intranasal pharmaceutical compositions with improved pharmacokinetics
|
|
WO2010135340A2
(en)
|
2009-05-18 |
2010-11-25 |
3M Innovative Properties Company |
Dry powder inhalers
|
|
ES2662769T3
(es)
|
2009-05-18 |
2018-04-09 |
Adamis Pharmaceuticals Corporation |
Contadores de dosis de inhalador de polvo seco
|
|
JP2012528844A
(ja)
|
2009-06-01 |
2012-11-15 |
バイオコピア リミテッド |
好中球によって引き起こされる疾患の治療におけるアンレキサノクスの使用
|
|
GB201111485D0
(en)
|
2011-07-05 |
2011-08-17 |
Biocopea Ltd |
Drug composition and its use in therapy
|
|
GB0917054D0
(en)
|
2009-09-29 |
2009-11-11 |
Cytoguide As |
Agents, uses and methods
|
|
TW201117824A
(en)
|
2009-10-12 |
2011-06-01 |
Amgen Inc |
Use of IL-17 receptor a antigen binding proteins
|
|
GB0918431D0
(en)
|
2009-10-21 |
2009-12-09 |
Prosonix Ltd |
Process for improving crystallinity
|
|
GB0921481D0
(en)
|
2009-12-08 |
2010-01-20 |
Vectura Ltd |
Process and product
|
|
MX2012011629A
(es)
|
2010-04-07 |
2013-03-05 |
Abbvie Inc |
Proteinas de union a tnf-alfa.
|
|
WO2012030664A1
(en)
|
2010-08-30 |
2012-03-08 |
Pulmatrix, Inc. |
Dry powder formulations and methods for treating pulmonary diseases
|
|
WO2012037665A1
(en)
|
2010-09-24 |
2012-03-29 |
Oral Delivery Technology Ltd. |
Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
|
|
WO2012041717A1
(en)
*
|
2010-09-30 |
2012-04-05 |
Chiesi Farmaceutici S.P.A. |
Use of magnesium stearate in dry powder formulations for inhalation
|
|
WO2012078804A1
(en)
|
2010-12-07 |
2012-06-14 |
Respira Therapeutics, Inc. |
Dry powder inhaler
|
|
CN102058886A
(zh)
|
2010-12-20 |
2011-05-18 |
云南白药集团无锡药业有限公司 |
医用粉雾剂及其应用
|
|
WO2012107364A1
(en)
|
2011-02-07 |
2012-08-16 |
Scipharm Sàrl |
Novel composition for the treatment of cystic fibrosis
|
|
GB201102237D0
(en)
|
2011-02-09 |
2011-03-23 |
Kuecept Ltd |
Particle formulation
|
|
CN108014340A
(zh)
|
2011-04-12 |
2018-05-11 |
莫伊莱麦屈克斯公司 |
用于预防或治疗以成纤维细胞异常增殖及细胞外基质沉积为特征的疾病的组合物和方法
|
|
US20120306613A1
(en)
|
2011-06-02 |
2012-12-06 |
Nokia Siemens Networks Oy |
Sensor allocation
|
|
US20140239525A1
(en)
|
2011-06-17 |
2014-08-28 |
Board Of Regents, University Of Texas System |
Inhalable pharmaceutical compositions
|
|
US20140234330A1
(en)
|
2011-07-22 |
2014-08-21 |
Amgen Inc. |
Il-17 receptor a is required for il-17c biology
|
|
EP2753323A1
(en)
|
2011-09-06 |
2014-07-16 |
Verona Pharma PLC |
Treating cough and tussive attacks
|
|
ES2644922T3
(es)
|
2011-12-16 |
2017-12-01 |
Indosys Limited |
Cartucho de dosis unitaria de medicamento y dispositivo de suministro
|
|
HK1205156A1
(en)
|
2012-01-31 |
2015-12-11 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for therapeutic delivery
|
|
CN107875127A
(zh)
*
|
2012-02-28 |
2018-04-06 |
艾塞尤提卡控股公司 |
可吸入药物组合物
|
|
US20150136130A1
(en)
|
2012-02-29 |
2015-05-21 |
Pulmatrix, Inc. |
Inhalable dry powders
|
|
AU2013240139B2
(en)
|
2012-03-26 |
2017-02-23 |
Arroyo Biosciences L.L.C. |
Novel sphingosine 1-phosphate receptor antagonists
|
|
GB201205632D0
(en)
|
2012-03-30 |
2012-05-16 |
Vectura Ltd |
Method and apparatus
|
|
CN111700878A
(zh)
|
2012-05-03 |
2020-09-25 |
卡拉制药公司 |
显示提高的粘膜转移的药物纳米粒子
|
|
SG11201407676VA
(en)
|
2012-05-21 |
2015-03-30 |
Agency Science Tech & Res |
A dry powder formulation
|
|
EP2863892B1
(en)
|
2012-06-20 |
2017-11-08 |
University Of Waterloo |
Mucoadhesive nanoparticle delivery system
|
|
WO2014048065A1
(en)
|
2012-09-28 |
2014-04-03 |
Merck Sharp & Dohme Corp. |
Triazolyl derivatives as syk inhibitors
|
|
EP2903622A1
(en)
|
2012-10-03 |
2015-08-12 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with invariant nkt cell agonists
|
|
US20150284381A1
(en)
|
2012-11-07 |
2015-10-08 |
Merck Sharp & Dohme Corp. |
Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors
|
|
US9757529B2
(en)
*
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
US9757395B2
(en)
*
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
CN110464724A
(zh)
|
2013-01-28 |
2019-11-19 |
理森制药股份公司 |
通过吸入罗氟司特n-氧化物治疗自身免疫、呼吸和/或炎性病症的方法
|
|
TWI643853B
(zh)
|
2013-02-27 |
2018-12-11 |
阿爾米雷爾有限公司 |
同時具有β2腎上腺素受體促效劑和M3毒蕈鹼受體拮抗劑活性之2-氨基-1-羥乙基-8-羥基喹啉-2(1H)-酮衍生物之鹽類
|
|
GB201305813D0
(en)
|
2013-03-28 |
2013-05-15 |
Vectura Ltd |
Compositions and methods
|
|
CN105473133A
(zh)
|
2013-04-30 |
2016-04-06 |
欧缇托匹克公司 |
干粉制剂及使用方法
|
|
EP2999337A4
(en)
|
2013-05-23 |
2017-03-15 |
Aztherapies, Inc |
Methods for delivering cromolyn
|
|
TWI641373B
(zh)
|
2013-07-25 |
2018-11-21 |
阿爾米雷爾有限公司 |
具有蕈毒鹼受體拮抗劑和β2腎上腺素受體促效劑二者之活性的2-胺基-1-羥乙基-8-羥基喹啉-2(1H)-酮衍生物之鹽
|
|
ES2959419T3
(es)
|
2013-10-11 |
2024-02-26 |
Pulmokine Inc |
Formulaciones secas por aspersión
|
|
ES2712129T3
(es)
|
2013-12-23 |
2019-05-09 |
Xiaoguang Wen |
Comprimido de doble capa y método de preparación del mismo
|
|
EP3107548B8
(en)
*
|
2014-02-20 |
2022-07-20 |
Otitopic Inc. |
Dry powder formulations for inhalation
|
|
CA3177696A1
(en)
|
2014-02-20 |
2015-08-27 |
Allergan, Inc. |
Complement component c5 antibodies
|
|
AU2015223056B2
(en)
|
2014-02-27 |
2020-10-01 |
Allergan, Inc. |
Complement Factor Bb antibodies
|
|
US10344037B2
(en)
|
2014-03-26 |
2019-07-09 |
Canget BioTek Pharma LLC |
Use of the FL-one hundred eighteen core chemical structure platform to generate FL-one hundred eighteen derivatives for treatment of human disease
|
|
WO2015153838A1
(en)
|
2014-04-02 |
2015-10-08 |
Rogne Bioscience Inc. |
Methods and compositions for treating inflammatory disorders
|
|
EP3129013A1
(en)
|
2014-04-10 |
2017-02-15 |
Crowley, Patrick |
Delivery of non-steroidal antiinflammatory agents to the brain via the nasal tract to treat neurological disorders
|
|
KR20150127315A
(ko)
|
2014-05-07 |
2015-11-17 |
삼성중공업 주식회사 |
밸러스트수 처리 장치
|
|
CA2991760C
(en)
*
|
2014-07-31 |
2025-05-06 |
Aspeya US Inc. |
DRY INHALATION POWDER FORMULATIONS
|
|
US20180056022A1
(en)
|
2015-03-21 |
2018-03-01 |
James Zhou Liu |
Hand-actuated dry powder inhaler and its use
|
|
WO2016176552A1
(en)
*
|
2015-04-30 |
2016-11-03 |
Otitopic Inc. |
Dry power formulations for inhalation
|
|
EP3463378A4
(en)
*
|
2016-06-03 |
2020-01-08 |
Otitopic Inc. |
DRY POWDER FORMULAS FOR INHALATION
|
|
CN106619549B
(zh)
*
|
2017-01-03 |
2019-12-06 |
江苏吴中医药集团有限公司苏州制药厂 |
一种替格瑞洛与阿司匹林复合片剂及其制备方法
|
|
CA3076353A1
(en)
*
|
2017-09-22 |
2019-03-28 |
Otitopic Inc. |
Dry powder compositions with magnesium stearate
|
|
US10786456B2
(en)
*
|
2017-09-22 |
2020-09-29 |
Otitopic Inc. |
Inhaled aspirin and magnesium to treat inflammation
|
|
JP7690081B1
(ja)
|
2024-03-14 |
2025-06-09 |
ミサワホーム株式会社 |
モバイルユニットの連結構造
|